Lower Risk for Asthma Seen With Younger Age at Natural Menopause
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 30, 2024 -- Women with younger age at natural menopause have a reduced risk for asthma, according to a study published online Oct. 29 in Menopause.
Durmalouk Kesibi, from York University in Toronto, and colleagues followed women aged 45 to 85 years for a 10-year period to examine the association between age at natural menopause and the incidence of asthma among nonsmokers. Age at natural menopause was categorized as 40 to 44, 45 to 49, 50 to 54 (reference), and 55 years and older.
The study included 14,406 postmenopausal women. Incident asthma was reported in 5.08 percent of the women. The researchers found that women with age at natural menopause of 40 to 44 years versus 50 to 54 years had a hazard ratio of 0.70 for asthma.
"This study highlights sex-based differences in asthma, with women at a greater risk for asthma than men in adulthood. It also showed that women with later onset of menopause are at greater risk than those with early onset of menopause," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "Clinicians should be aware of this link and should monitor women with later age at natural menopause for asthma symptoms."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-31 06:00
Read more
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep
- Comorbid Diabetes Increases Risk for Lower Extremity Amputation With Kidney Disease
- AHA and ACC Update Cardiovascular Management Guideline for Noncardiac Surgery
- Availability, Timeliness of Availability of New Cancer Drugs Vary
- Falls Requiring Medical Attention Tied to Later Dementia Diagnosis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions